Amanda Dinaro FDA Investigator Profile

Fill out the form on the right to get in touch with Redica Systems.

FDA Investigator Profiles from Redica Systems, the parent company of FDAzilla, include the following data points (and more):

• Total number of inspections
• 483 issuance rate
• Resulting Warning Letter rate (FDA Investigators don't directly issue Warning Letters themselves, but the agency decides whether or not to issue a Warning Letter based on the Investigator's report.)
• Trends of the Investigator's last 10 inspections
• Top 5 cited categories

Amanda Dinaro Details

This InspectorProfile report is updated through Apr 2023 and lists Amanda Dinaro's inspections in 6 countries: United States, China, Taiwan, Hungary, Germany, and Israel. They recently co-inspected with Shafiq Ahadi, Marissa Steinhagen, Naashon Deberry, Emma Schaefer, and Brian Emanuel.

Inspector Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer grants you access to not only unlimited access to profiles like the one above for every current and former FDA Investigator, but also:

• Inspection Intelligence
  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year.
• Supplier Intelligence
  • Full inspection histories for your suppliers down to the specific site level
  • All of the functionality mentioned above but isolated to just your suppliers
• Regulatory Intelligence
  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more.

Fill out the form on the right to get in touch with Redica Systems.